Latest1 information on COVID-19

Clinical Trials Contact

About this Clinical Trial

Dose Escalation Study of CLR 131 in Children, Adolescents, and Young Adults With Relapsed or Refractory Malignant Tumors Including But Not Limited to Neuroblastoma, Rhabdomyosarcoma, Ewings Sarcoma, and Osteosarcoma

Your Message Will Go To

Richard Fu

1 650-497-8815


All fields are required. *

Preferred contact method*

To:

Richard Fu

1 650-497-8815



Go Back To The Trial

We were not able to send your contact info at this time.

Go Back To The Trial

©2022 Stanford Medicine